Clinical Genetic Testing and Interpretation Services

The contract calls for the provision of CLIA-certified genetic testing services, specifically focusing on whole exome sequencing and the generation of interpretive reports that connect identified genetic variants to clinical phenotypes for the diagnosis of rare diseases. The work must be performed in compliance with all applicable clinical laboratory standards and requires the technical expertise to analyze complex genomic data and deliver actionable, clinically relevant interpretations. The services are intended to support diagnostic efforts within a research or clinical setting, with deliverables centered on accurate, evidence-based reporting that aids in patient care and rare disease identification. This is a subcontract under the National Institutes of Health, part of the Department of Health and Human Services, with performance required at the Bethesda location with a zip code of 20892. The solicitation was posted on July 28, 2026, and responses are due by August 7, 2026, with a NAICS code of 621511 indicating it falls under medical and diagnostic laboratories. There is no set-aside designation noted, and the contract does not include specific point of contact details, but interested parties must adhere to the submission deadline and ensure full compliance with CLIA and clinical reporting standards to be considered for award.